TerrAscend Corp. ( TSNDF) - Key Metrics
TSNDF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.21 | -$0.03 | $0.02 | $0.02 |
| 2026Q1 | $0.21 | -$0.03 | $0.03 | $0.02 |
| 2025Q4 | $0.20 | $0.01 | $0.03 | $0.02 |
| 2025Q3 | $0.21 | -$0.08 | $0.01 | $0 |
| 2025Q2 | $0.22 | -$0.17 | $0.01 | $0 |
TSNDF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -5.87 |
| 2026Q1 | 0% | -6.24 |
| 2025Q4 | 0% | 22.26 |
| 2025Q3 | 0% | -2.47 |
| 2025Q2 | 0% | -2.71 |
TSNDF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 2.33% | 0% |
| 2026Q1 | 3.85% | 0% |
| 2025Q4 | 2.91% | 0% |
| 2025Q3 | 0.24% | 0% |
| 2025Q2 | 0.75% | 0% |
TSNDF
Price: $0.51
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.04 USD
P/E Ratio: 15.88
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 197.0 million